Strides Acrolab Singapore acquires International Headquarters status by EDB
The status has been awarded by Singapore Economic Development Board (EDB).
Mumbai, January 13, 2015: Strides Acrolab today announced that the Singapore-based wholly owned subsidiary Strides Pharma Global has been awarded ‘International Headquarters Status’ by the Singapore Economic Development Board (EBD).
The company plans to carry out its international business activities involving business development and planning, sales and marketing, intellectual property management and global supply chain management and global regulatory affairs.
The company said in a statement that Singapore was selected as the International headquarters after assessing various options. Strides Pharma Global, Singapore will also be building a new manufacturing facility in Singapore in the next couple of years with focus on the regulated and South East Asia markets.